Pillar Excellence
Excellent science raises the level of excellence in Europe's science base and ensures a steady stream of world-class research to secure Europe's long-term competitiveness.
The Excellent Science pillar has four specific objectives:
- The European Research Council (ERC) provides attractive and flexible funding to enable talented and creative individual researchers and their teams to pursue the most promising avenues at the frontier of science.
- Future and Emerging Technologies (FET) supports collaborative research in order to extend Europe's capacity for advanced and paradigm-changing innovation. They foster scientific collaboration across disciplines on radically new, high-risk ideas and accelerate development of the most promising emerging areas of science and technology.
- Marie Sklodowska-Curie Actions (MSCA) provide excellent and innovative research training as well as attractive career and knowledge-exchange opportunities through cross-border and cross-sector mobility of researchers to best prepare them to face current and future societal challenges.
- Research Infrastructures (including e-infrastructures) (RI) develops European research infrastructure for 2020 and beyond, foster their innovation potential and human capital, and complement this with the related Union policy and international cooperation.
Testimonial
BEAT-AF - Ground-Breaking Electroporation-based intervention for Atrial Fibrillation treatment
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
